A study found that mothers who experienced childhood adversity, such as abuse or neglect, are more likely to face mental health challenges during pregnancy and postpartum. These challenges can negatively impact their children’s mental health, leading to issues like anxiety, depression, and social withdrawal. Brain imaging showed weaker connectivity between emotional regulation centers in children of affected mothers, highlighting the intergenerational effects of trauma.

A study by NIH researchers revealed that Cognitive Behavioral Therapy (CBT) alters brain activity in children with anxiety. Before treatment, overactivity in areas like the frontal lobe and amygdala was observed. After 12 weeks of CBT, significant improvements in anxiety symptoms were recorded, along with reduced brain activity in these regions, indicating the effectiveness of CBT in managing anxiety disorders.

An NIH-supported study revealed that patterns of brain activity following a traumatic event can help predict mental health outcomes, such as PTSD and anxiety, six months later. The research, part of the AURORA study, used brain imaging to identify different stress-related activity profiles, providing insight into personalized mental health care after trauma.

A study found that persistent feelings of detachment, or derealization, after trauma may indicate a higher risk of developing PTSD, depression, or anxiety. Brain scans revealed altered activity in regions related to emotion regulation, supporting the need to screen for dissociation after trauma to identify those at risk for worsening mental health outcomes.

An NIH study identified shared genetic markers across multiple substance use disorders, including alcohol, nicotine, cannabis, and opioid use. By analyzing genomic data from over a million individuals, researchers discovered links between these disorders and dopamine regulation genes. These findings could inform improved prevention and treatment strategies for substance use disorders.

The Early Psychosis Intervention Network (EPINET), supported by NIMH, has expanded its reach, improving access to treatment and research resources for early psychosis care. By connecting regional hubs and clinics, the initiative provides data-driven, coordinated care for individuals experiencing early psychosis. EPINET aims to ensure that patients receive the best research-based treatment, improving recovery outcomes nationwide.

A study highlighted disparities in the diagnosis of psychotic disorders across racial and ethnic groups in the U.S. Black, American Indian, and Alaskan Native individuals were diagnosed with psychotic disorders at higher rates, leading to poorer mental and physical health outcomes, including comorbid conditions and reduced health care access. These findings stress the need for equitable mental health care.

A study identified a neural marker linked to social impairment in people with psychotic disorders like schizophrenia. Reduced brain activity in specific regions, such as the ventral striatum and orbital frontal cortex, was associated with social anhedonia—a lack of interest in social connections. This finding may lead to improved diagnosis and treatment of social difficulties in psychotic disorders.

An NIH study identified shared genetic markers across multiple substance use disorders, including alcohol, nicotine, cannabis, and opioid use. By analyzing genomic data from over a million individuals, the researchers found links between these disorders and dopamine regulation genes. The findings may lead to improved treatment and prevention strategies for substance use disorders.

A large NIMH-supported genetic study identified rare variants in 10 genes that significantly increase the risk of developing schizophrenia. These genes are involved in critical brain functions, such as neuronal communication and synaptic functioning. Understanding these genetic variations may lead to new treatment targets for this mental disorder, offering hope for better therapeutic options in the future.